Inhibition of Protease Activated Receptor 2 Attenuates HBx-Induced Inflammation and Mitochondria Oxidative Stress

References

• Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-480:672–686.
   PubMed Web of Science ®Google Scholar
• Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64(1):51–68.
   PubMed Web of Science ®Google Scholar
• Yang S, Yu C, Chen P, et al. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China. Sci Rep. 2015;5:18334.
   PubMed Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–1129.
   PubMed Web of Science ®Google Scholar
• Slagle BL, Andrisani OM, Bouchard MJ, Lee CG, Ou JH, Siddiqui A. Technical standards for hepatitis B virus X protein (HBx) research. Hepatology. 2015;61(4):1416–1424.
   Web of Science ®Google Scholar
• Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–283.
   PubMed Web of Science ®Google Scholar
• Martin-Vilchez S, Moreno-Otero R, Sanz-Cameno P. Effects of hepatitis B virus X protein on chronic hepatitis B pathophysiology. Med Clin (Barc). 2013;140(11):508–513.
   Web of Science ®Google Scholar
• Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol. 2000;74(6):2840–2846.
   PubMed Web of Science ®Google Scholar
• Lee YI, Hwang JM, Im JH, et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem. 2004;279(15):15460–15471.
   PubMed Web of Science ®Google Scholar
• Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol. 2011;26(Suppl 1):173–179.
   PubMed Web of Science ®Google Scholar
• Wong VW, Yu J, Cheng AS, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009;124(12):2766–2770.
   PubMed Web of Science ®Google Scholar
• Quetier I, Brezillon N, Duriez M, et al. Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. J Hepatol. 2013;59(2):285–291.
   Web of Science ®Google Scholar
• Gruden G, Carucci P, Lolli V, et al. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. Cell Stress Chaperones. 2013;18(2):235–241.
   Web of Science ®Google Scholar
• Lan T, Chang L, Wu L, Yuan YF. IL-6 Plays a Crucial Role in HBV Infection. J Clin Transl Hepatol. 2015;3(4):271–276.
   PubMedGoogle Scholar
• Xie L, Huang Y. Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes. Artif Cells Nanomed Biotechnol. 2019;47(1):1194–1199.
   PubMed Web of Science ®Google Scholar
• Fan Y, Wang L, Dou X. Serum Monocyte Chemoattractant Protein-1 Predicts Liver Inflammation of Patients with Chronic Hepatitis B. Clin Lab. 2018;64(5):841–846.
   Web of Science ®Google Scholar
• Luo MX, Wong SH, Chan MT, et al. Autophagy Mediates HBx-Induced Nuclear Factor-kappaB Activation and Release of IL-6, IL-8, and CXCL2 in Hepatocytes. J Cell Physiol. 2015;230(10):2382–2389.
   Web of Science ®Google Scholar
• Frungieri MB, Albrecht M, Raemsch R, Mayerhofer A. The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2). Cell Signal. 2005;17(4):525–533.
   Web of Science ®Google Scholar
• Lee YJ, Kim SJ, Kwon KW, Lee WM, Im WJ, Sohn UD. Inhibitory effect of FSLLRY-NH2 on inflammatory responses induced by hydrogen peroxide in HepG2 cells. Arch Pharm Res. 2017;40(7):854–863.
   Web of Science ®Google Scholar
• Antoniak S, Pawlinski R, Mackman N. Protease-activated receptors and myocardial infarction. IUBMB Life. 2011;63(6):383–389.
   Web of Science ®Google Scholar
• El-Daly M, Pulakazhi Venu VK, Saifeddine M, et al. Hyperglycaemic impairment of PAR2-mediated vasodilation: prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress. Vascul Pharmacol. 2018;109:56–71.
   PubMed Web of Science ®Google Scholar
• Aman M, Hirano M, Kanaide H, Hirano K. Upregulation of proteinase-activated receptor-2 and increased response to trypsin in endothelial cells after exposure to oxidative stress in rat aortas. J Vasc Res. 2010;47(6):494–506.
   Web of Science ®Google Scholar
• Walker JK, DeFea KA. Role for beta-arrestin in mediating paradoxical beta2AR and PAR2 signaling in asthma. Curr Opin Pharmacol. 2014;16:142–147.
   PubMed Web of Science ®Google Scholar
• Rayees S, Rochford I, Joshi JC, Joshi B, Banerjee S, Mehta D. Macrophage TLR4 and PAR2 Signaling: role in Regulating Vascular Inflammatory Injury and Repair. Front Immunol. 2020;11:2091.
   Web of Science ®Google Scholar
• Lee HM, Kim HY, Kang HJ, et al. Up-regulation of protease-activated receptor 2 in allergic rhinitis. Ann Otol Rhinol Laryngol. 2007;116(7):554–558.
   Web of Science ®Google Scholar
• Noorbakhsh F, Vergnolle N, McArthur JC, et al. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol. 2005;174(11):7320–7329.
   PubMed Web of Science ®Google Scholar
• Weithauser A, Bobbert P, Antoniak S, et al. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol. 2013;62(19):1737–1745.
   Web of Science ®Google Scholar
• Chen P, Yang N, Xu L, Zhao F, Zhang M. Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma. Infect Agent Cancer. 2019;14:39.
   Web of Science ®Google Scholar
• Shearer AM, Rana R, Austin K, et al. Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin. J Biol Chem. 2016;291(44):23188–23198.
   Web of Science ®Google Scholar
• Yip WK, Cheng AS, Zhu R, et al. Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS One. 2011;6(8):e22888.
   Web of Science ®Google Scholar
• Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6(7):1258–1266.
   PubMed Web of Science ®Google Scholar
• Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A. 2002;99(21):13825–13830.
   PubMed Web of Science ®Google Scholar
• Hu L, Chen L, Yang G, et al. HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer. 2011;10:43.
   PubMed Web of Science ®Google Scholar
• Xie WH, Ding J, Xie XX, et al. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflamm Res. 2020;69(7):683–696.
   PubMed Web of Science ®Google Scholar
• Casciano JC, Bouchard MJ. Hepatitis B virus X protein modulates cytosolic Ca(2+) signaling in primary human hepatocytes. Virus Res. 2018;246:23–27.
   Web of Science ®Google Scholar
• Shirakata Y, Koike K. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem. 2003;278(24):22071–22078.
   Web of Science ®Google Scholar
• Tan C, Guo H, Zheng M, Chen Y, Huang W. Involvement of mitochondrial permeability transition in hepatitis B virus replication. Virus Res. 2009;145(2):307–311.
   Web of Science ®Google Scholar
• Gearhart TL, Bouchard MJ. Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology. 2010;407(1):14–25.
   PubMed Web of Science ®Google Scholar
• Bonino F, Ponzetto A, Veglio V, Bosio G, Zaffino MC, Rizzetto M. The immunological diagnosis of HBsAg liver disease by combined screening for the e system in the serum and the HB core and surface antigens in liver biopsy samples. Ric Clin Lab. 1977;7(4):365–372.
   Google Scholar
• Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Front Immunol. 2019;10:2048.
   PubMed Web of Science ®Google Scholar
• Hu L, Chen L, Yang G, et al. HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer. 2011;10(43):1476–4598.
   Google Scholar
• Bang E, Kim DH, Chung HY. Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-κB and FoxO6 modulation during skin photoaging. Redox Biol. 2021;44(102022):26.
   Google Scholar
• Ling LR, Zheng DH, Zhang ZY, et al. Effect of HBx on inflammation and mitochondrial oxidative stress in mouse hepatocytes. Oncol Lett. 2020;19(4):2861–2869.
   Web of Science ®Google Scholar
• He P, Lei J, Miao JN, Wu D, Wang C. Cordyceps sinensis attenuates HBx-induced cell apoptosis in HK-2 cells through suppressing the PI3K/Akt pathway. Int J Mol Med. 2020;45(4):1261–1269.
   Web of Science ®Google Scholar
• Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol. 2008;83(6):1309–1322.
   PubMed Web of Science ®Google Scholar
• Chen L, Gao B, Zhang Y, et al. PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway. J Cell Biochem. 2019;120(6):9799–9809.
   PubMed Web of Science ®Google Scholar
• Liang DY, Sha S, Yi Q, et al. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-kappaB pathway. Cell Signal. 2019;62:109346.
   Web of Science ®Google Scholar
• Xia L, Tian D, Huang W, et al. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-kappaB pathway. J Immunol. 2012;188(2):753–764.
   Web of Science ®Google Scholar
• Chiu AP, Tschida BR, Sham TT, et al. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism. Mol Cancer Res. 2019;17(7):1582–1593.
   Web of Science ®Google Scholar
• Xu QG, Yuan SX, Tao QF, et al. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. J Hepatol. 2019;70(5):904–917.
   PubMed Web of Science ®Google Scholar
• Du C, Zhang T, Xiao X, Shi Y, Duan H, Ren Y. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway. Biochem J. 2017;474(16):2733–2747.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Lim J, Wu KC, Xu W, Suen JY, Fairlie DP. PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR. Br J Pharmacol. 2021;178(4):913–932.
   Web of Science ®Google Scholar
• Hu L, Xia L, Zhou H, et al. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCalpha and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620. Tumour Biol. 2013;34(5):2573–2581.
   Google Scholar
• Mohamed DI, Khairy E, Khedr SA, Habib EK, Elayat WM, El-Kharashi OA. N-acetylcysteine (NAC) alleviates the peripheral neuropathy associated with liver cirrhosis via modulation of neural MEG3/PAR2/ NF-B axis. Neurochem Int. 2020;132:104602.
   Web of Science ®Google Scholar
• Xie L, Zheng Y, Li X, et al. Enhanced proliferation of human hepatoma cells by PAR-2 agonists via the ERK/AP-1 pathway. Oncol Rep. 2012;28(5):1665–1672.
   Web of Science ®Google Scholar